Erlanger Health System, in Partnership with MDP Management and Agathos, Sustains a Culture of Clinical Excellence Through Physician Engagement and Ongoing Performance Improvement

SAN FRANCISCO, Sept. 25, 2019 /PRNewswire/ — Agathos is pleased to announce its partnership with Erlanger Health System and MDP Management, a Chattanooga-based hospitalist group, to help manage practice variation. With leadership from David Alvarez MD and the rest of the MDP team, Agathos helps Erlanger scale the “last mile” of physician engagement toward valuable care. Erlanger Health System is a nationally acclaimed, multi-hospital health system treating more than 600,000 people annually:

  • The 10th-largest public healthcare system in the United States
  • Part of the Vanderbilt Health Affiliated Network—56 hospitals and 4,000 providers
  • The Tri-state region’s only Level I Trauma Center

After supporting MDP hospitalists at Erlanger through numerous quality initiatives, Agathos looks forward to expanding the relationship to physicians in other acute care specialties, starting with emergency medicine.

“We are excited to work side-by-side with Erlanger’s attending physicians and support delivery of the highest quality, most compassionate care in the region,” said Andrew Trees, CEO of Agathos. “Erlanger Health System has long enjoyed exceptional clinician buy-in to quality improvement initiatives, and its leadership continues to commit to providing physicians the best, most cutting-edge technology in support of measurable clinical excellence.”

Agathos’ transparency platform leverages the following principles designed to put physicians at the helm of their own clinical autonomy while empowering teams to collaborate, learn, and improve together:

  • ACCURATE ATTRIBUTION of all clinical actions and decisions to correct physician(s)
  • ACTION-LEVEL FEEDBACK specific to items physicians directly control and influence
  • PEER COMPARISONS for relative performance assessment, creating tension for change and positive deviance
  • CASE EXAMPLE(S) that further validate attribution, invite timely reflection, and facilitate collaboration
  • INSIGHTS VIA TEXT for efficient and effective communication

ABOUT AGATHOS
Agathos is the transparency platform, by physicians for physicians, giving superior feedback on practice variation— scaling the “last mile” of physician engagement toward valuable care. We partner with health systems—maximizing the benefits of technology investments already made—to empower each physician toward ever-higher quality, cost stewardship, and organizational alignment.

Media Contact:
Vladimir Tikhtman, Head of Marketing
Telephone: 312-497-5519
Email: 223505@email4pr.com
Website: https://www.agathos.io/

View original content:http://www.prnewswire.com/news-releases/erlanger-health-system-in-partnership-with-mdp-management-and-agathos-sustains-a-culture-of-clinical-excellence-through-physician-engagement-and-ongoing-performance-improvement-300924493.html

SOURCE Agathos

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

3 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

17 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

18 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

18 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

19 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

20 hours ago